Friday, 20 September 2019

FDA approves oral diabetes drug from Novo Nordisk

FDA approves oral diabetes drug from Novo NordiskThe U.S. Food and Drug Administration on Friday approved an oral version of Novo Nordisk's diabetes drug semaglutide, a boost for the Danish drugmaker, which hopes to transform the market by offering patients a noninjectable treatment.




from Yahoo News - Latest News & Headlines https://ift.tt/2ABqa4O
via IFTTT

at
Labels: , , , , ,

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

Ex-Syrian intelligence chief found guilty of torture and sexual abuse by Austrian court

Two former Syrian officials went on trial in Vienna, Austria, accused of crimes against opponents of former Syrian leader Bashar al-Assad ...